May 31, 2011

U.S. National BioGENEius Challenge finalists in Delaware honored

DOVER, Del. (May 31, 2011) – Governor Jack Markell joined Kelvin Lee, director of the Delaware Biotechnology Institute, to recognize three finalists from Delaware schools named to the U.S. National BioGENEius Challenge, a competition for high school students who demonstrate an exemplary understanding of biotechnology through science research projects.


State competitions were held on March 7 at Sussex County Science Fair and March 10 at the New Castle County Science Expo. The finalists from Delaware include Priyen Patel, 16, of Sussex Technical High School and Achille Tenkiang, 15, and Jaewoong Yoo, 17, of The Charter School of Wilmington.

“Innovation is part of Delaware’s DNA,” Governor Markell said. “We have made supporting science, technology, engineering and math education a priority because of those subjects’ critical role in the health and welfare of our economy and our citizens. As a nation, we need to own molecular innovation this century as thoroughly as we led in mechanical innovation in the last. Priyen, Achille and Jaewoong are showing that we can.”

The three Delaware finalists will now advance to the U.S. National BioGENEius Challenge on June 25, 2011 in Washington, D.C. Ten national finalists will have a chance to compete at the International BioGENEius Challenge competition, which will be held June 27, 2011 at the 2011 Biotechnology Industry Organization (BIO) International Convention in Washington, D.C. Representatives from the Delaware Economic Development Office and the state’s biotechnology industry will be attending the convention. Winners of the competition will be announced at the June 28th keynote luncheon.

At the Local, U.S. National and International competitions, students are evaluated on the quality of their research and display, as well as on their responses to questions relating to their scientific knowledge and potential commercial applications of their research.

“The judges were impressed with the enthusiasm for science demonstrated by all the students, but they were especially excited by the initiative and the accomplishments of these three individuals,” said Kelvin Lee, director of the Delaware Biotechnology Institute. “From their work on bio-based fuel cells, to gene silencing in plants, to pharmaceuticals in our water supply, their results are a model of how science can transform our society in a positive way, and are strong examples of current world issues.”

The International BioGENEius Challenge is organized by the Biotechnology Institute, the national organization dedicated to biotechnology education, and sponsored by Sanofi Pasteur, the vaccines division of the sanofi-aventis Group, a leading global pharmaceutical company, and Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD), one of the Janssen Pharmaceutical Companies. The local Delaware competition is sponsored by AstraZeneca and the Delaware Biotechnology Institute faculty and staff.

“For more than 15 years, the aim of the International BioGENEius Challenge has been to engage, excite and educate students about biotechnology and its immense potential for solving human health, food and environmental problems,” says Tom Wiggans, Chairman of The Biotechnology Institute. “By highlighting the amazing research of these students, we hope to encourage other students to consider pursuing a career in biotechnology.”

At the BIO International Convention, judges will select the top four winners from 14 U.S. National, Western Australia, and Canada finalists. The first place winner of the BioGENEius Challenge will receive $7,500; second place will receive $5,000; third place will receive $2,500 and fourth place will receive $1,000. Each remaining participant will receive an honorable mention award and $500.

The International BioGENEius Challenge, which emerged from the Sanofi Pasteur (then called Connaught) BioGENEius Challenge, was launched at the first BIO International Convention in 1994. Today, the initiative has grown in both national and international prominence.

About the Delaware Economic Development Office

The Delaware Economic Development Office is an executive state agency responsible for attracting new investors and businesses to the state, promoting the expansion of existing industry, assisting small and minority-owned businesses, promoting and developing tourism and creating new and improved employment opportunities for all citizens of the State. Visit dedo.delaware.gov. Follow DEDO on Facebook or Twitter @DEDOgov.

About the Delaware Biotechnology Institute

The Delaware Biotechnology Institute is a partnership among government, academia and industry to help establish the First State as a center of excellence in biotechnology and the life sciences. The Institute mission is to facilitate a biotechnology network of people and facilities to enhance existing academic and private-sector research, catalyze unique cross-disciplinary research and education initiatives, and to foster the entrepreneurship that creates high-quality jobs.

About the Biotechnology Institute

The Biotechnology Institute is an independent, national nonprofit organization dedicated to education about the present and future impact of biotechnology. Its mission is to engage, excite and educate the public, particularly students and teachers, about biotechnology and its immense potential for solving human health, food and environmental problems. For more information, visit www.biotechinstitute.org.

May 26, 2011

Messages from Delaware's Congressional Delegation

Delaware is fortunate to have public officials at both the State and Federal levels who understand and value the importance of the BIO Industry.

U.S. Senators Tom Carper and Chris Coons, and U.S. Representative John Carney are all excited about the BIO International Convention and hope all at BIO will have a chance to come to the Delaware Pavilion (booth 2359).





May 17, 2011

Delaware Governor Jack Markell speaks about BIO

Governor Jack Markell is a strong proponent of the Bio Industry, he's worked closely with the Delaware BioScience Association and has demonstrated consistent leadership in promoting Bio - recognizing both the economic and societal benefits that result from this industry advancing our understanding of health and the environment.

The Governor says his hope is that all who attend the BIO International Convention would have a chance to talk with the men and women from Delaware who make a difference in the Bio Community.


May 16, 2011

Message from Delaware Economic Development Director Alan Levin

Alan Levin served as President and CEO of Happy Harry's, the tenth largest drugstore chain in the United States, until it was acquired by the Walgreen Company in July 2006. During his tenure, he grew revenues tenfold to nearly half a billion dollars, 76 locations and 2,700 employees.

Today, Alan is the Director of the Delaware Economic Development Office, he works with Governor Markell to grow businesses in Delaware and he has a strong relationship with the Bio Industry.

Here's Alan's message for all attending the BIO 2011 International Conference:

May 12, 2011

Great story from Delaware First Media about BIO 2011

Delaware First Media has published a great article about BIO 2011 and Delaware's participation, here's a couple of excerpts:


“Everything that’s necessary for the biotech industry is here,” said SDIX President and CEO Fran DiNuzzo. “It’s a vibrant and tight biotech community.”
The SDIX story is one that Delaware officials are now aiming to replicate in the hope of building on a flourishing local industry that generates billions of dollars and thousands of jobs for the state’s economy.
At the BIO International Convention – the world’s biggest biotechnology trade show — in Washington, DC from June 27-30, Delaware officials and industry leaders will be working to attract new business to the state and reinforce its reputation as a leading center for the industry.
“We are trying to create a big splash,” said Alan Levin, Secretary of the Delaware Economic Development Office. “We now have an opportunity to put ourselves in a bigger market for the next generation.”
...
“It’s an opportunity to get people to come to Delaware,” said Bob Dayton, President of the Delaware BioScience Association referring to the convention. “They might stop off and visit before or after the show, especially international visitors.”
Dayton says the state’s participation in the DC show coincides with an increase in its ongoing efforts to boost the local life-sciences industry. The Delaware BioScience Association had 30 members at its inception five years ago. Today it has grown to a 100-member trade group that represents about 80 percent of the state’s biotech industry.